Glen Cove, United States
Epicured is a health care company delivering science-backed nutrition solutions to combat chronic disease. Founded in 2015 and headquartered in the United States, Epicured focuses on providing therapeutic medically-tailored menus for individuals diagnosed with IBS, IBD, Crohn's, and Colitis. Their marquee offering is a 100% low FODMAP and gluten-free menu, designed to eliminate hard-to-digest carbohydrates and sugars. This unique approach aims to make managing dietary restrictions more accessible and exciting.
The latest milestone for Epicured was the Series A investment secured on 05 April 2021, with Purple Sage Ventures as the lead investor. This funding signals growing interest and confidence in the company's mission and offerings within the Food and Beverage, Health Care, and Nutrition industries. As they continue to expand and innovate, Epicured's impact on the health and well-being of those managing chronic diseases is becoming increasingly evident.
